Jade Biosciences, Inc. - 10-Q Filing
Jade Biosciences, Inc. reports Q3 2025 financial results featuring significant R&D and G&A expenditures alongside complex equity instrument activity.
Tickers: $AVTE
More Regulatory news
- Milestone Pharmaceuticals Inc. - 8-K Filing
- Lument Finance Trust, Inc. - 10-Q Filing
- MILESTONE SCIENTIFIC INC. - 10-Q Filing
- XTI Aerospace, Inc. - 8-K Filing
- Jade Biosciences, Inc. - 8-K Filing
- IMMUNIC, INC. - 10-Q Filing
- REGIS CORP - 8-K Filing
- Fathom Holdings Inc. - 10-Q Filing
- MAMMOTH ENERGY SERVICES, INC. - 8-K Filing
- QXO, Inc. - 10-Q Filing